Mark Hagler

Corporate Officer/Principal at NOVABRIDGE BIOSCIENCES

Net worth: 194 964 $ as of 30/06/2026

Consumer Services

Health Technology

Profile

Mark A. Hagler is currently Chief Financial Officer & Director at SLAM BioTherapeutics, Inc. Mr. Hagler is also set to be Chief Commercial Officer at NovaBridge Biosciences starting in 2026.
Mr. Hagler holds an MBA from The Johns Hopkins University and an undergraduate degree from the United States Naval Academy.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NOVABRIDGE BIOSCIENCES 0.12%	24/04/2026	2,30,000 ( 0.12% )	194 964 $	30/06/2026

Mark Hagler active positions

Companies	Position	Start
NOVABRIDGE BIOSCIENCES	Corporate Officer/Principal	01/07/2026

All active positions of Mark Hagler

Training of Mark Hagler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Hagler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
United States Naval Academy United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
I-Mab I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases	Health Technology